Every week in my practice, patients tell me the same thing: "I've been told there's nothing left to do but wait for a joint replacement." That sentence troubles me, because science keeps pushing forward. And a recent discovery from Yale University is genuinely worth paying attention to.
What the Yale researchers found
Scientists identified an existing epilepsy drug called lacosamide that acts on a protein involved in two simultaneous processes: pain signal transmission and progressive cartilage destruction.
What makes this discovery especially interesting is that it is not simply a painkiller. In preclinical studies, lacosamide showed the ability to push damaged joints toward repair rather than just relief. In other words, it may not only ease pain, but also help cartilage rebuild itself.
Why this is different from current treatments
Today, most osteoarthritis treatments rest on three pillars:
- Anti-inflammatory drugs and painkillers, to manage symptoms
- Physiotherapy and osteopathy, to maintain mobility and strengthen surrounding structures
- Surgery, as a last resort, when cartilage is too severely degraded
None of these treatments truly addresses the root cause: the progressive destruction of cartilage. If confirmed in human trials, lacosamide would represent a genuinely new category of treatment, one capable of acting on the biology of the joint itself.
What this means for you, concretely
We must remain cautious: these are preclinical studies, conducted in the laboratory and in animal models. The path to a treatment available to patients is still long. These results do not mean you should ask your doctor for this drug today.
But what this research confirms is important: osteoarthritis is not an unchangeable fate. Joint biology can be influenced. Understanding these mechanisms also helps explain why approaches like osteopathy, which act on mobility, circulation, and surrounding tensions, make sense within a broader care strategy.
The role of osteopathy while waiting for therapeutic advances
While treatments like this one work through the necessary clinical stages, there are concrete things we can do right now.
In my practice in Tel Aviv, I regularly work with patients suffering from knee, hip, or shoulder osteoarthritis. Osteopathy does not regenerate cartilage, to be clear. But it can:
- Reduce the muscular and fascial tensions that overload the joint
- Improve overall mobility and limit compensation in other areas
- Relieve pain durably, by working on the full articular chain
- Support a return to adapted physical activity, which is essential for nourishing remaining cartilage
Movement remains the best ally for your joints. And news from research, like this finding from Yale, reinforces the idea that it is better to act early and holistically.
If you are living with osteoarthritis and want to explore what osteopathy can do for you, I invite you to book an appointment at my practice in Tel Aviv. Together, we will build a strategy adapted to your situation, without waiting for the pain to become unbearable.
